Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Aquestive Therapeutics revenue
Aquestive Therapeutics's revenue is $57.6 million.
What is Aquestive Therapeutics's revenue?
- Aquestive Therapeutics's revenue growth from 2017 to 2024 is -13.98%.
- Aquestive Therapeutics has 100 employees, and the revenue per employee ratio is $575,610.
- Aquestive Therapeutics's peak quarterly revenue was $21.7M in 2020(q2).
- Aquestive Therapeutics peak revenue was $67.4M in 2018.
- Aquestive Therapeutics annual revenue for 2023 was 50.6M, 6.09% growth from 2022.
- Aquestive Therapeutics annual revenue for 2024 was 57.6M, 13.8% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Aquestive Therapeutics historical revenue
Aquestive Therapeutics's peak revenue was $67.4M in 2018. The peak quarterly revenue was $21.7M in 2020(q2).
Aquestive Therapeutics's revenue increased from $66.9m in 2017 to $57.6M currently. That's a -13.98% change in annual revenue.
Aquestive Therapeutics annual revenue
Aquestive Therapeutics annual revenue over time
| Fiscal year / year | Aquestive Therapeutics revenue |
|---|---|
| 2017 | $66.9M |
| 2018 | $67.4M |
| 2019 | $52.6M |
| 2020 | $45.8M |
| 2021 | $50.8M |
| 2022 | $47.7M |
| 2023 | $50.6M |
| 2024 | $57.6M |
Rate Aquestive Therapeutics' financial transparency
Aquestive Therapeutics annual growth
Aquestive Therapeutics saw the greatest revenue growth in 2021, when revenue increased by 10.87%.
Aquestive Therapeutics had the lowest revenue growth in 2019, when revenue changed by -21.98%.
Aquestive Therapeutics annual growth rate over time
| Year | Aquestive Therapeutics growth |
|---|---|
| 2018 | 1%↑ |
| 2019 | -22%↓ |
| 2020 | -13%↓ |
| 2021 | 11%↑ |
| 2022 | -6%↓ |
| 2023 | 6%↑ |
| 2024 | 14%↑ |
Aquestive Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Aquestive Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | $13.9M | $13.3M | $16.8M |
| 2019 | $12.6M | $11.1M | $12.4M | $16.4M |
| 2020 | $8.8M | $21.7M | $8.3M | $7.1M |
| 2021 | $11.1M | $15.3M | $13.3M | $11.1M |
| 2022 | $12.3M | $13.3M | $11.5M | $10.7M |
| 2023 | $11.1M | $13.2M | $13.0M | $13.2M |
| 2024 | $12.1M | $20.1M | $13.5M | $11.9M |
Aquestive Therapeutics jobs nearby
Do you work at Aquestive Therapeutics?
Is Aquestive Therapeutics transparent about its revenue structure?
Aquestive Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 100 |
| Date Founded | 2004 |
| Headquarters | Warren, New Jersey |
| Number of Locations | 2 |
| Revenue | $57.6M |
| Net Income | -$54,410,000 |
| Tax Rate | 0.0% |
| Total Assets | $57,070,000 |
| Ticker | AQST |
Aquestive Therapeutics jobs you might like
Aquestive Therapeutics financing
Aquestive Therapeutics received early financing of $38.0M on 2006-12-14.
| Series | Round size | Date |
|---|---|---|
| Private Equity | $38M | 12/2006 |
| Debt Financing | $2.5M | 03/2008 |
| Debt Financing | $10M | 06/2008 |
| Debt Financing | $20M | 09/2008 |
| Debt Financing | $50M | 08/2016 |
| Series Unknown | $9M | 04/2018 |
| Post Ipo Debt | $70M | 07/2019 |
Aquestive Therapeutics investors
| Investors | Security type |
|---|---|
| White Oak Global Advisors, LLC | Debt Financing |
| CNF Investments LLC | Debt Financing |
| Edward P. Bass Group | Debt Financing |
| HALIFAX GROUP | Debt Financing |
| Perceptive Advisors | Debt Financing |
| Madryn Asset Management | Post Ipo Debt |
Aquestive Therapeutics revenue FAQs
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Aquestive Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aquestive Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Aquestive Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aquestive Therapeutics. The data presented on this page does not represent the view of Aquestive Therapeutics and its employees or that of Zippia.
Aquestive Therapeutics may also be known as or be related to AQUESTIVE THERAPEUTICS, INC., Aquestive Therapeutics and Aquestive Therapeutics, Inc.